Literature DB >> 7541851

Subcutaneous urinary diversions for palliative treatment of pelvic malignancies.

F Desgrandchamps1, O Cussenot, P Meria, A Cortesse, P Teillac, A Le Duc.   

Abstract

PURPOSE: We developed 2 subcutaneous urinary diversion techniques, pyelovesical bypass and anterior cutaneous nephrostomy, to improve the quality of life of patients undergoing permanent palliative percutaneous nephrostomy.
MATERIALS AND METHODS: A total of 21 patients underwent either pyelovesical bypass (19) or anterior cutaneous nephrostomy (13). Technically, the percutaneous nephrostomy tube is replaced by a self-retaining expanded polytetrafluoroethylene-silicone tube tunneled underneath the skin. The distal extremity can be either introduced into the bladder, creating a pyelovesical bypass, or brought out directly through a cutaneous orifice, creating an anterior cutaneous nephrostomy.
RESULTS: No tube was dislodged and none became obstructed due to incrustation or angulation. Standard percutaneous nephrostomy was necessary in 1 patient in each group. Improvement in the quality of life was stressed by all patients. Pyelovesical bypass eliminates external drainage and anterior cutaneous nephrostomy performed when the bladder is no longer functional allows for the creation of a single, easily dressed anterior stoma.
CONCLUSIONS: Pyelovesical bypass and anterior cutaneous nephrostomy constitute valuable alternatives to standard permanent palliative percutaneous nephrostomy.

Entities:  

Mesh:

Year:  1995        PMID: 7541851     DOI: 10.1097/00005392-199508000-00008

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

1.  [Prosthetic pyelovesical and pyelocutanous bypass. A palliative therapy concept in tumor-induced chronic hydronephprosis].

Authors:  H Loertzer; A Jurczok; S Wagner; P Fornara
Journal:  Urologe A       Date:  2003-05-27       Impact factor: 0.639

2.  Simultaneous bilateral subcutaneous pyelovesical bypass as a salvage procedure in refractory retroperitoneal fibrosis.

Authors:  Nicholas Haddad; Sero Andonian; Maurice Anidjar
Journal:  Can Urol Assoc J       Date:  2013 May-Jun       Impact factor: 1.862

3.  [Long-term results for subcutaneous Detour® prosthesis for ureteral obstruction: experiences of implantation, aftercare and management of complications].

Authors:  A Janitzky; J Borski; M Porsch; J J Wendler; D Baumunk; U-B Liehr; M Schostak
Journal:  Urologe A       Date:  2012-12       Impact factor: 0.639

4.  Subcutaneous pyelovesical bypass - Detour bypass - as a solution for ureteric obstruction.

Authors:  Andrzej Jerzy Wrona; Jarosław Zgajewski; Norbert Kopeć; Dominik Chodor; Paweł Kopcza; Stefan Klekot
Journal:  Cent European J Urol       Date:  2017-10-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.